Literature DB >> 26936875

N-sulfation of heparan sulfate is critical for syndecan-4-mediated podocyte cell-matrix interactions.

Terrel Sugar1, Deborah J Wassenhove-McCarthy2, A Wayne Orr2, Jonette Green2, Toin H van Kuppevelt3, Kevin J McCarthy4.   

Abstract

Previous research has shown that podocytes unable to assemble heparan sulfate on cell surface proteoglycan core proteins have compromised cell-matrix interactions. This report further explores the role of N-sulfation of intact heparan chains in podocyte-matrix interactions. For the purposes of this study, a murine model in which the enzyme N-deacetylase/N-sulfotransferase 1 (NDST1) was specifically deleted in podocytes and immortalized podocyte cell lines lacking NDST1 were developed and used to explore the effects of such a mutation on podocyte behavior in vitro. NDST1 is a bifunctional enzyme, ultimately responsible for N-sulfation of heparan glycosaminoglycans produced by cells. Immunostaining of glomeruli from mice whose podocytes were null for Ndst1 (Ndst1(-/-)) showed a disrupted pattern of localization for the cell surface proteoglycan, syndecan-4, and for α-actinin-4 compared with controls. The pattern of immunostaining for synaptopodin and nephrin did not show as significant alterations. In vitro studies showed that Ndst1(-/-) podocytes attached, spread, and migrated less efficiently than Ndst1(+/+) podocytes. Immunostaining in vitro for several markers for molecules involved in cell-matrix interactions showed that Ndst1(-/-) cells had decreased clustering of syndecan-4 and decreased recruitment of protein kinase-Cα, α-actinin-4, vinculin, and phospho-focal adhesion kinase to focal adhesions. Total intracellular phospho-focal adhesion kinase was decreased in Ndst1(-/-) compared with Ndst1(+/+) cells. A significant decrease in the abundance of activated integrin α5β1 on the cell surface of Ndst1(-/-) cells compared with Ndst1(+/+) cells was observed. These results serve to highlight the critical role of heparan sulfate N-sulfation in facilitating normal podocyte-matrix interactions.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  glycosaminoglycans; heparan sulfate; podocyte; proteoglycans; syndecan

Mesh:

Substances:

Year:  2016        PMID: 26936875      PMCID: PMC5002056          DOI: 10.1152/ajprenal.00603.2015

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  54 in total

1.  Localization of transgenes and genotyping of H-2kb-tsA58 transgenic mice.

Authors:  Georg Kern; Bernhard E Flucher
Journal:  Biotechniques       Date:  2005-01       Impact factor: 1.993

Review 2.  The structure and function of the endothelial glycocalyx layer.

Authors:  Sheldon Weinbaum; John M Tarbell; Edward R Damiano
Journal:  Annu Rev Biomed Eng       Date:  2007       Impact factor: 9.590

3.  Influence of high glucose concentrations on the expression of glycosaminoglycans and N-deacetylase/N-sulphotransferase mRNA in cultured skin fibroblasts from diabetic patients with or without nephropathy.

Authors:  Benito Yard; Yuxi Feng; Hanno Keller; Christa Mall; Fokko van Der Woude
Journal:  Nephrol Dial Transplant       Date:  2002-03       Impact factor: 5.992

4.  Syndecan-4 associates with alpha-actinin.

Authors:  Daniel K Greene; Sarka Tumova; John R Couchman; Anne Woods
Journal:  J Biol Chem       Date:  2002-12-18       Impact factor: 5.157

5.  Heparan sulfate regulates targeting of syndecan-1 to a functional domain on the cell surface.

Authors:  Yang Yang; Magne Børset; J Kevin Langford; Ralph D Sanderson
Journal:  J Biol Chem       Date:  2003-02-03       Impact factor: 5.157

6.  A new method for large scale isolation of kidney glomeruli from mice.

Authors:  Minoru Takemoto; Noomi Asker; Holger Gerhardt; Andrea Lundkvist; Bengt R Johansson; Yasushi Saito; Christer Betsholtz
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

Review 7.  Interactions between heparan sulfate and proteins: the concept of specificity.

Authors:  Johan Kreuger; Dorothe Spillmann; Jin-ping Li; Ulf Lindahl
Journal:  J Cell Biol       Date:  2006-07-31       Impact factor: 10.539

8.  Syndecan-4 phosphorylation is a control point for integrin recycling.

Authors:  Mark R Morgan; Hellyeh Hamidi; Mark D Bass; Stacey Warwood; Christoph Ballestrem; Martin J Humphries
Journal:  Dev Cell       Date:  2013-02-28       Impact factor: 12.270

9.  Fibronectin localization in the rat glomerulus.

Authors:  P J Courtoy; Y S Kanwar; R O Hynes; M G Farquhar
Journal:  J Cell Biol       Date:  1980-12       Impact factor: 10.539

10.  Podocyte-specific deletion of NDST1, a key enzyme in the sulfation of heparan sulfate glycosaminoglycans, leads to abnormalities in podocyte organization in vivo.

Authors:  Terrel Sugar; Deborah J Wassenhove-McCarthy; Jeffrey D Esko; Toin H van Kuppevelt; Lawrence Holzman; Kevin J McCarthy
Journal:  Kidney Int       Date:  2013-08-07       Impact factor: 10.612

View more
  5 in total

Review 1.  Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?

Authors:  Caroline B Marshall
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-31

2.  Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.

Authors:  Sanjeev Sethi; Benjamin J Madden; Hanna Debiec; M Cristine Charlesworth; LouAnn Gross; Aishwarya Ravindran; Amber M Hummel; Ulrich Specks; Fernando C Fervenza; Pierre Ronco
Journal:  J Am Soc Nephrol       Date:  2019-05-06       Impact factor: 10.121

Review 3.  Podocyte-actin dynamics in health and disease.

Authors:  Luca Perico; Sara Conti; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

Review 4.  Physiology and Pathophysiology of Heparan Sulfate in Animal Models: Its Biosynthesis and Degradation.

Authors:  Ryuichi Mashima; Torayuki Okuyama; Mari Ohira
Journal:  Int J Mol Sci       Date:  2022-02-10       Impact factor: 5.923

Review 5.  Prospects for Precision Medicine in Glomerulonephritis Treatment.

Authors:  Yulu Cherry Liu; Justin Chun
Journal:  Can J Kidney Health Dis       Date:  2018-02-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.